These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17604498)

  • 1. The future of the oral pharmacotherapy of male erectile dysfunction: things to come.
    Uckert S; Mayer ME; Stief CG; Jonas U
    Expert Opin Emerg Drugs; 2007 May; 12(2):219-28. PubMed ID: 17604498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future trends in the oral pharmacotherapy of male erectile dysfunction.
    Uckert S; Stief CG; Jonas U
    Expert Opin Investig Drugs; 2003 Sep; 12(9):1521-33. PubMed ID: 12943496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The basics of phosphodiesterase type 5 (PDE5) inhibition in urology].
    Becker AJ; Uckert S; Stief CG
    Urologe A; 2008 Dec; 47(12):1582-7. PubMed ID: 18854969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of erectile dysfunction and lower urinary tract symptoms by phosphodiesterase inhibitors.
    Uckert S; Stief CG
    Handb Exp Pharmacol; 2011; (204):307-22. PubMed ID: 21695646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
    Sperling H; Lümmen G; Schneider T; Rübben H
    Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erectile function disorders. Epidemiology, physiology, etiology, diagnosis and therapy].
    Derouet H; Osterhage J; Sittinger H
    Nervenarzt; 2004 Jun; 75(6):595-605; quiz 606-7. PubMed ID: 15281210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic targets for erectile dysfunction.
    Williams SK; Melman A
    Maturitas; 2012 Jan; 71(1):20-7. PubMed ID: 22154078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
    Hatzimouratidis K; Hatzichristou DG
    Drugs; 2005; 65(12):1621-50. PubMed ID: 16060698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A; Ryder RE
    Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.
    Carson CC; Hatzichristou DG; Carrier S; Lording D; Lyngdorf P; Aliotta P; Auerbach S; Murdock M; Wilkins HJ; McBride TA; Colopy MW;
    BJU Int; 2004 Dec; 94(9):1301-9. PubMed ID: 15610110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study.
    Dean J; Hackett GI; Gentile V; Pirozzi-Farina F; Rosen RC; Zhao Y; Warner MR; Beardsworth A
    J Sex Med; 2006 Jul; 3(4):650-661. PubMed ID: 16839321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
    Tolrà JR; Campaña JMC; Ciutat LF; Miranda EF
    J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of phosphodiesterase 5 inhibition in erectile dysfunction.
    Rosen RC; Kostis JB
    Am J Cardiol; 2003 Nov; 92(9A):9M-18M. PubMed ID: 14609619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract.
    Uckert S; Kuczyk MA
    Handb Exp Pharmacol; 2011; (202):527-42. PubMed ID: 21290241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing and managing erectile dysfunction after prostatectomy for prostate cancer.
    Albaugh JA
    Urol Nurs; 2010; 30(3):167-177, 166. PubMed ID: 20648854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological management of erectile dysfunction.
    Montorsi F; Salonia A; Deho' F; Cestari A; Guazzoni G; Rigatti P; Stief C
    BJU Int; 2003 Mar; 91(5):446-54. PubMed ID: 12603396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological therapy of erectile dysfunction].
    Becker AJ; Stief CG; Schultheiss D; Truss MC; Jonas U
    Urologe A; 1998 Sep; 37(5):503-8. PubMed ID: 9796031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey.
    Kim NN
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S13-9. PubMed ID: 14551572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New oral drugs for erectile dysfunction.
    Drug Ther Bull; 2004 Jul; 42(7):49-52. PubMed ID: 15270071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.